3H-[1,2,3]triazolo[4,5-d]pyrimidine compounds, their use as mTOR kinase and PI3 kinase inhibitors, and their syntheses
Details for Australian Patent Application No. 2009205501 (hide)
International Classifications
Event Publications
5 August 2010 PCT application entered the National Phase
PCT publication WO2009/091788 Priority application(s): WO2009/091788
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2009205523-Compositions, methods, and kits for detecting ribonucleic acid
2009205489-Policy control and charging (PCC) rules based on mobility protocol
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser